Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

A comprehensive repertoire of tRNA-derived fragments in prostate cancer

Open access
Olvedy, Michael, Scaravilli, Mauro, Hoogstrate, Youri, Visakorpi, Tapio, Jenster, Guido, Martens-Uzunova, Elena S. · 2016 · Oncotarget

Abstract

// Michael Olvedy 1, 4, 5, * , Mauro Scaravilli 2, 3, * , Youri Hoogstrate 1 , Tapio Visakorpi 2, 3, # , Guido Jenster 1, # , Elena S. Martens-Uzunova 1, # 1 Department of Urology, Erasmus MC, Rotterdam, The Netherlands 2 Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland 3 Fimlab Laboratories, Tampere University Hospital, Tampere, Finland 4 Current address: VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium 5 Current address: Center for Human Genetics, KULeuven, Leuven, Belgium * These authors contributed equally to this work # Three last authors contributed equally to this work Correspondence to: Elena S. Martens-Uzunova, e-mail: e.martens@erasmusmc.nl Keywords: tRNA-derived fragments (tRFs), prostate cancer (PCa), RNA-sequencing, non-coding RNA, biomarker Received: September 04, 2015 Accepted: March 02, 2016 Published: March 23, 2016 ABSTRACT Prostate cancer (PCa) is the most common cancer among men in developed countries. Although its genetic background is thoroughly investigated, rather little is known about the role of small non-coding RNAs (sncRNA) in this disease. tRNA-derived fragments (tRFs) represent a new class of sncRNAs, which are present in a broad range of species and have been reported to play a role in several cellular processes. Here, we analyzed the expression of tRFs in fresh frozen patient samples derived from normal adjacent prostate and different stages of PCa by RNA-sequencing. We identified 598 unique tRFs, many of which are deregulated in cancer samples when compared to normal adjacent tissue. Most of the identified tRFs are derived from the 5’- and 3’-ends of mature cytosolic tRNAs, but we also found tRFs produced from other parts of tRNAs, including pre-tRNA trailers and leaders, as well as tRFs from mitochondrial tRNAs. The 5’-derived tRFs comprise the most abundant class of tRFs in general and represent the major class among upregulated tRFs. The 3’-derived tRFs types are dominant among downregulated tRFs in PCa. We validated the expression of three tRFs using qPCR. The ratio of tRFs derived from tRNA LysCTT and tRNA PheGAA emerged as a good indicator of progression-free survival and a candidate prognostic marker. This study provides a systematic catalogue of tRFs and their dysregulation in PCa and can serve as the basis for further research on the biomarker potential and functional roles of tRFs in this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8293

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 170

Metadata

Authors
Olvedy, M., Scaravilli, M., Hoogstrate, Y., Visakorpi, T., Jenster, G., & Martens-Uzunova, E. S.
Venue
Oncotarget
Published
2016-03-23
Volume
7
Issue
17
Pages
24766-24777
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2303912045
Cited by
170
References
6
FWCI
7.22
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A comprehensive repertoire of tRNA-derived fragments in prostate cancer. https://app.cochat.ai/papers/10.18632/oncotarget.8293
The paper
Olvedy, M., Scaravilli, M., Hoogstrate, Y., Visakorpi, T., Jenster, G., & Martens-Uzunova, E. S. (2016). A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget. https://doi.org/10.18632/oncotarget.8293

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.